Paolo Verdecchia Selected Research

Nitric Oxide (Nitrogen Monoxide)

12/2015	Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications.
4/2008	[Obesity and hypertension].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Verdecchia Research Topics

Disease

47	Hypertension (High Blood Pressure) 11/2022 - 08/2002
23	Atrial Fibrillation 10/2021 - 05/2012
22	Stroke (Strokes) 11/2022 - 09/2004
14	Cardiovascular Diseases (Cardiovascular Disease) 02/2021 - 11/2003
11	Heart Failure 07/2021 - 01/2004
10	Myocardial Infarction 07/2021 - 11/2005
10	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019 - 01/2004
9	Hemorrhage 04/2019 - 01/2015
8	Type 2 Diabetes Mellitus (MODY) 01/2021 - 04/2004
7	COVID-19 05/2022 - 01/2020
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 09/2005
6	Chronic Renal Insufficiency 11/2022 - 04/2011
5	Inflammation (Inflammations) 01/2022 - 12/2015
5	Insulin Resistance 01/2022 - 01/2004
5	Infarction (Infarctions) 01/2021 - 01/2010
5	Thromboembolism 02/2019 - 04/2013
5	Diabetes Mellitus 05/2017 - 11/2009
5	Hypertrophy 05/2011 - 10/2002
5	Essential Hypertension 01/2007 - 03/2002
4	Embolism (Embolus) 04/2019 - 01/2013
3	Thrombosis (Thrombus) 01/2022 - 01/2020
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2021 - 06/2008
3	Ischemic Stroke 04/2019 - 01/2014
3	Proteinuria 02/2012 - 01/2009
3	Diabetic Nephropathies (Diabetic Nephropathy) 04/2011 - 08/2007
3	Obesity 04/2008 - 01/2004
2	Hyperuricemia 01/2022 - 01/2021
2	Kidney Diseases (Kidney Disease) 01/2022 - 01/2021
2	Atherosclerosis 01/2022 - 01/2008
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2021 - 01/2013
2	Pneumonia (Pneumonitis) 01/2020 - 01/2020
2	Pain (Aches) 11/2018 - 12/2010
2	Osteoarthritis 11/2018 - 12/2010
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 11/2010
2	Hyperglycemia 12/2015 - 01/2015
2	Myocardial Ischemia (Ischemic Heart Diseases) 04/2013 - 01/2010
2	Acute Coronary Syndrome 08/2012 - 03/2012
1	Hypertensive Crisis 02/2022
1	Albuminuria 01/2022
1	Gout 01/2022
1	Coronary Restenosis 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Pulmonary Arterial Hypertension 12/2021

Drug/Important Bio-Agent (IBA)

18	Angiotensin Receptor AntagonistsIBA 01/2022 - 04/2004
18	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 01/2004
17	AnticoagulantsIBA 04/2019 - 01/2013
14	DiureticsIBA 11/2022 - 09/2003
14	Antihypertensive Agents (Antihypertensives)IBA 12/2021 - 10/2002
10	Pharmaceutical PreparationsIBA 12/2020 - 08/2002
9	Uric Acid (Urate)IBA 11/2022 - 01/2020
9	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 02/2022 - 09/2004
9	Vitamin K FDA Link 11/2018 - 05/2012
9	Dabigatran FDA Link 11/2018 - 01/2013
9	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 01/2013
7	aliskiren FDA Link 01/2014 - 01/2007
6	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2005
6	Ramipril (Altace)FDA LinkGeneric 11/2017 - 10/2009
5	Angiotensin IIIBA 01/2022 - 01/2008
5	apixabanIBA 02/2019 - 01/2014
5	Telmisartan (Micardis)FDA Link 11/2017 - 10/2009
4	CreatinineIBA 01/2022 - 04/2010
4	CholesterolIBA 01/2021 - 01/2004
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2014 - 10/2009
3	Ethanol (Ethyl Alcohol)IBA 11/2022 - 01/2020
3	LDL CholesterolIBA 11/2022 - 01/2020
3	VaccinesIBA 05/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2010
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 06/2011
3	CatecholaminesIBA 09/2019 - 01/2015
3	edoxabanIBA 12/2017 - 01/2014
3	N(4)-oleylcytosine arabinosideIBA 03/2017 - 01/2014
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2012 - 03/2012
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2017
2	Celecoxib (Celebrex)FDA Link 11/2018 - 08/2010
2	Amlodipine (Norvasc)FDA LinkGeneric 11/2018 - 09/2005
2	RivaroxabanIBA 12/2017 - 06/2017
2	Adrenergic Agents (Adrenergic Drugs)IBA 12/2015 - 01/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2015 - 04/2008
2	Renin InhibitorsIBA 07/2012 - 01/2007
2	Metformin (Glucophage)FDA LinkGeneric 10/2011 - 06/2011
2	Valsartan (Vals)FDA Link 05/2010 - 04/2004
2	HDL CholesterolIBA 03/2009 - 02/2006
2	MercuryIBA 12/2006 - 08/2006
2	1,4-dihydropyridine (dihydropyridine)IBA 09/2005 - 09/2004
1	AlbuminsIBA 01/2022
1	Allopurinol (Remid)FDA LinkGeneric 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	CD40 Ligand (CD40L)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Endothelin Receptor AntagonistsIBA 12/2021
1	macitentanIBA 12/2021
1	aprocitentanIBA 12/2021

Therapy/Procedure

21	Therapeutics 10/2021 - 03/2002
2	Denervation 03/2022 - 11/2014
2	Percutaneous Coronary Intervention 01/2022 - 10/2021
2	Contraindications 10/2021 - 08/2007
1	Drug Therapy (Chemotherapy) 02/2022
1	Stents 01/2022